Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Hsu

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Annals of the Rheumatic Diseases|March 16, 2011
Predicting the outcome of ankylosing spondylitis therapyNathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Arthritis Care & Research|March 2, 2010
Impact of systemic lupus erythematosus on health, family, and work: the patient perspectiveDon Robinson, Daniel Aguilar, Melissa Schoenwetter, et al.
Rheumatology (Oxford, England)|July 11, 2013
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisDaniel E Furst, Jonathan Kay, Mary Chester Wasko, et al.
Arthritis and Rheumatism|July 31, 2013
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosusJacek C Szepietowski, Surasak Nilganuwong, Anna Wozniacka, et al.
Lancet (London, England)|September 26, 2018
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled studyRonald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Cell|June 27, 2025
Virtual Cell Challenge: Toward a Turing test for the virtual cellYusuf H Roohani, Tony J Hua, Po-Yuan Tung, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Annals of the Rheumatic Diseases|March 16, 2011
Predicting the outcome of ankylosing spondylitis therapyNathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Arthritis Care & Research|March 2, 2010
Impact of systemic lupus erythematosus on health, family, and work: the patient perspectiveDon Robinson, Daniel Aguilar, Melissa Schoenwetter, et al.
Rheumatology (Oxford, England)|July 11, 2013
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisDaniel E Furst, Jonathan Kay, Mary Chester Wasko, et al.
Arthritis and Rheumatism|July 31, 2013
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosusJacek C Szepietowski, Surasak Nilganuwong, Anna Wozniacka, et al.
Lancet (London, England)|September 26, 2018
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled studyRonald F van Vollenhoven, Bevra H Hahn, George C Tsokos, et al.
Cell|June 27, 2025
Virtual Cell Challenge: Toward a Turing test for the virtual cellYusuf H Roohani, Tony J Hua, Po-Yuan Tung, et al.
Pageof 5